Page 1

October 9 , 2026 CrycCell INTERNATIONAL Cord Blood Banking Leader Cryo - Cell Reports Fiscal Third Quarter 2026 Financial Results OLDSMAR , Fla .-- ( BUSINESS WIRE ) -- Cryo - Cell International , Inc. ( NYSE American , Symbol : CCEL ) ( the “ Company ” , “ Cryo - Cell " ) , the world's first private cord blood bank to separate and store stem cells in 1992 , announced results for the fiscal third quarter ended August 31 , 2026 . Financial Results Revenue Consolidated revenues for the third quarter of fiscal 2026 were $ 7.82 million compared to $ 7.83 million for the third quarter of fiscal 2025 . Net Income The Company reported net income of $ 1.27 million , or $ 0.16 per basic and diluted share , for the three months ended August 31 , 2026 , compared to net income of $ 749,000 , or $ 0.09 per basic and diluted share , for the three months ended August 31 , 2025 . About Cryo - Cell International , Inc. Founded in 1989 , Cryo - Cell International , Inc. is the world's first private cord blood bank . The Company , together with its global affiliates , stores more than 250,000 cord blood and cord tissue specimens for the exclusive benefit of newborn babies and their families . In addition to its private bank , Cryo - Cell International , Inc. has a public banking program in partnership with Duke University . Cryo - Cell's public bank has provided cord blood for more than 900 transplants . Cryo - Cell's facility is FDA - registered , cGMP- / CGTP - compliant , and licensed in all states requiring licensure . In addition to AABB accreditation as a cord blood facility , Cryo - Cell was the first U.S. private ( family - use ) cord blood bank to receive FACT accreditation for adhering to the most stringent cord blood quality standards set by any internationally recognized , independent accrediting organization . Cryo - Cell holds exclusive rights to PrepaCyte - CB , the industry's most advanced cord blood processing technology . Cryo - Cell's mission is to provide clients with the premier cord blood and cord tissue cryopreservation service and to aid in the advancement of regenerative medicine . Forward - Looking Statements This press release includes " forward - looking statements " within the meaning of Section 27A of the Securities Act of 1933 , as amended ( the “ Securities Act " ) and Section 21E of the Securities Exchange Act of 1934 , as amended ( the “ Exchange Act ” ) . In some cases , you can identify forward - looking statements by terminology such as “ will , ” “ may , ” “ should , ” " could , " " would , ” “ expects , ” “ plans , ” “ anticipates , ” “ believes , ” “ estimates , ” “ predicts , " " forecasts , " " potential ” or “ continue ” or the negative of these terms or other comparable